Top Markets
#1 Islamic Coin Islamic Coin +151.49%
#2 DOVU DOVU +47.86%
#3 Velvet Velvet +43.20%
#4 Akedo Akedo +42.96%
#5 Black Phoenix Black Phoenix +34.22%
#6 Cross Cross +21.95%
#7 DoubleZero DoubleZero +17.10%
#8 Cap Cap +16.75%
#9 Tutorial Tutorial +15.51%
#10 Not in Employment, Education, or Training Not in Employment, Education, or Training +9.76%
Coin of the day
Islamic Coin Islamic Coin
Ustawienia
Język
POLSKI
Waluta
USD
Motyw
PHAXIAM Therapeutics S.A. PHAXIAM Therapeutics S.A.

PHAXIAM Therapeutics S.A.

PHXM
Pozycja w akcjach #39465
PHAXIAM Therapeutics S.A. is a biopharmaceutical firm dedicated to creating... PHAXIAM Therapeutics S.A. is a biopharmaceutical firm dedicated to creating therapies for drug-resistant bacterial infections, operating in both France and the U.S. The company's pipeline includes eryaspase, currently undergoing Phase 3 clinical trials for advanced pancreatic cancer and Phase 2 studies for treating triple-negative breast cancer and acute lymphoblastic leukemia after initial treatments. Additionally, PHAXIAM is advancing a range of phage therapies designed to combat hazardous, drug-resistant bacteria. These pathogens, such as Staphylococcus aureus, Escherichia coli, and Pseudomonas aeruginosa, are responsible for over two-thirds of all resistant infections acquired in hospital settings. Established in 2004, the company was previously known as ERYTECH Pharma S.A. before adopting the name PHAXIAM Therapeutics S.A. in June 2023. Its corporate headquarters are located in Lyon, France.
Cena akcji
$0.11725176
Ostatnia synchronizacja: 2025-07-14
Kapitalizacja rynkowa
$481.50K
Zmiana (1 dzień)
-0.20%
Zmiana (1 rok)
0.00%
Kraj
FR
Handel PHAXIAM Therapeutics S.A. (PHXM)

Kategoria

Healthcare
EPS dla PHAXIAM Therapeutics S.A. (PHXM)
EPS na dzień June 2024 TTM: $-4.23
Według najnowszych raportów finansowych i ceny akcji firmy PHAXIAM Therapeutics S.A., obecny EPS (TTM) wynosi $-4.23. Na koniec roku 2022 firma miała EPS w wysokości $-0.07, spadek w porównaniu do do EPS z roku 2021, który wynosił $-23.87.
Historia EPS dla PHAXIAM Therapeutics S.A. od 2016 do 2026
EPS na koniec każdego roku
Rok EPS Zmień
2026 (TTM) $-4.23 -23.50%
2023 $-5.53 7,492.45%
2022 $-0.07 -99.69%
2021 $-23.87 -46.82%
2020 $-44.88 23.87%
2019 $-36.23 60.03%
2018 $-22.64 -30.76%
2017 $-32.70 21.96%
2016 $-26.81 0.00%
EPS dla podobnych firm lub konkurentów
Firma EPS Różnica w EPS Kraj
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $17.32 -509.44%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $27.74 -755.76%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 - -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 $13.70 -423.86%
BE